https://www.selleckchem.com/products/unc0379.html
Adjustment for individual FRAX® fracture risk assessment scores was included. BPs, predominantly alendronate, were used by 9.4% of the women and 1.5% of the men. During a median of 5.2years of follow-up, 265 women and 133 men had a hip fracture, and 662 women and 127 men had a forearm fracture. Compared with non-users of BPs, the hazard ratios with 95% confidence interval for a fracture among users of BPs adjusted for age and FRAX® were 0.67 (0.52-0.86) for women and 1.13 (0.50-2.57) for men. Among users of glucocorticoids, the correspo
Like
Comment
Share
